Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Neoplasms, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00281658
What this trial is testing

Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 444
Not applicableStudy completedNCT05923268
What this trial is testing

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

Who this might be right for
Breast Cancer Female
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Early research (Phase 1)Study completedNCT02684032
What this trial is testing

Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Celcuity Inc 141
Early research (Phase 1)UnknownNCT03487055
What this trial is testing

Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases

Who this might be right for
Breast Cancer
Jiangsu T-Mab Biopharma Co.,Ltd 30
Early research (Phase 1)Ended earlyNCT07408089
What this trial is testing

Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer
Boundless Bio, Inc. 8
Not applicableNot Yet RecruitingNCT06449417
What this trial is testing

Aurora: a Human-centered Program for Breast Cancer Patients in Chile, Easing Neoadjuvant Chemotherapy's Effects

Who this might be right for
Breast Cancer
Pontificia Universidad Catolica de Chile 30
Testing effectiveness (Phase 2)Looking for participantsNCT07612891
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)Advanced Solid CancersMetastatic (Stage IV) Breast Cancer+2 more
Shenzhen Ionova Life Sciences Co., Ltd.
Testing effectiveness (Phase 2)Looking for participantsNCT06956690
What this trial is testing

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

Who this might be right for
Melanoma (Skin)Non Small Cell Lung CancerBreast Cancer
Hummingbird Bioscience 180
Very early researchStudy completedNCT04289532
What this trial is testing

Integrin α6-targeted SPECT Imaging of Breast Cancer

Who this might be right for
Breast Cancer
Peking University 9
Early research (Phase 1)Active Not RecruitingNCT05809752
What this trial is testing

A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

Who this might be right for
Leptomeningeal DiseaseTriple Negative Breast CancerHER2-positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Large-scale testing (Phase 3)Active Not RecruitingNCT04842617
What this trial is testing

Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative

Who this might be right for
Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 5,274
Early research (Phase 1)Active Not RecruitingNCT05653752
What this trial is testing

YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer

Who this might be right for
Non Small Cell Lung CancerBreast Cancer
MediLink Therapeutics (Suzhou) Co., Ltd. 80
Early research (Phase 1)Study completedNCT04905667
What this trial is testing

Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®

Who this might be right for
Breast Cancer
Genor Biopharma Co., Ltd. 87
Not applicableStudy completedNCT04460911
What this trial is testing

Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.

Who this might be right for
Breast Cancer
Pfizer 317
Large-scale testing (Phase 3)Study completedNCT03176238
What this trial is testing

Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

Who this might be right for
Post Menopausal Breast Cancer
Novartis Pharmaceuticals 235
Not applicableLooking for participantsNCT07754500
What this trial is testing

Deep Optical Imaging of Tissue (DOIT)

Who this might be right for
Healthy TissueMusclesExtremity+1 more
Lund University 60
Not applicableLooking for participantsNCT07273812
What this trial is testing

Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients

Who this might be right for
Breast CancerBreast NeoplasmChemotherapy-Related Toxicities+4 more
Dena h. Al-Tameemi 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT06394661
What this trial is testing

Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Who this might be right for
Breast Cancer
Henan Cancer Hospital 109
Early research (Phase 1)Ended earlyNCT05080842
What this trial is testing

AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer

Who this might be right for
Breast Cancer
Accutar Biotechnology Inc 21
Not applicableUnknownNCT01677520
What this trial is testing

Investigation of Stem Cells in Human Lipoaspirate

Who this might be right for
Breast Cancer
University of Nevada, Las Vegas 240
Next Page
201